McGladrey Margaret, Kelsch Jordan, Lofwall Michelle R, Fanucchi Laura C, Walsh Sharon L, Oser Carrie B
Center for Innovation in Population Health, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.
Substance Use Priority Research Area, University of Kentucky, Lexington, Kentucky, USA.
J Correct Health Care. 2024 Feb;30(1):3-6. doi: 10.1089/jchc.23.08.0065. Epub 2023 Dec 26.
In a case example from the Kentucky HEALing Communities Study, extensive resources were deployed to address structural barriers and facilitate the provision of medication for opioid use disorder (OUD) in an urban county jail. However, implementation was unsuccessful, and this case example emphasizes the importance of including evidence-based medication for OUD (MOUD) treatment in the scope of work of jails' contracted medical providers. The privatization of correctional health care services allows local governments with opioid abatement funds to incorporate requirements into medical provider contracts to screen all people entering jails for OUD and to offer MOUD at intake, throughout incarceration, and upon release to everyone for whom it is clinically indicated. We provide sample contractual language that can be added to requests for medical provider proposals to help drive the private correctional health care market toward integrating MOUD treatment into their standard of care. This approach also could expedite efforts to scale up broad MOUD access across U.S. jails through sharing of workflows and best practices among the small group of national correctional health care companies contracted with jails in states with broad mandates, such as Massachusetts. Clinical Trial Registration: NCT04111939.
在肯塔基州康复社区研究的一个案例中,大量资源被用于解决结构性障碍,并为一个城市县监狱中患有阿片类药物使用障碍(OUD)的人提供药物治疗。然而,实施并不成功,这个案例强调了在监狱签约医疗服务提供者的工作范围内纳入基于证据的阿片类药物使用障碍药物治疗(MOUD)的重要性。惩教医疗服务的私有化使拥有阿片类药物减排资金的地方政府能够在医疗服务提供者合同中纳入要求,对所有进入监狱的人进行OUD筛查,并在入狱时、监禁期间以及释放时为所有临床指征适用的人提供MOUD。我们提供了示例合同语言,可添加到医疗服务提供者提案请求中,以帮助推动私人惩教医疗市场将MOUD治疗纳入其护理标准。这种方法还可以通过在与马萨诸塞州等具有广泛授权的州的监狱签约的一小部分全国性惩教医疗公司之间共享工作流程和最佳实践,加快扩大美国监狱广泛获得MOUD治疗的努力。临床试验注册:NCT04111939。